Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
Pharmaceutical companies are optimistic about their growth prospects under a Trump administration following former President Joe Biden’s tough stance on…
Category: Departments Finance
Healthy Returns: Biotech, pharma M&A is picking up — but will it last?
A version of this article was initially featured in CNBC’s Healthy Returns newsletter, delivering the latest health-care news directly to…
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
In this article, Eli Lilly fell short of profit and revenue expectations for the third quarter due to disappointing sales…
RFK Jr. stumbles over Medicare, Medicaid basics during Senate hearings
Robert F. Kennedy Jr., President Donald Trump’s nominee for the Department of Health and Human Services, faced scrutiny for his…
Walgreens shares soar 27% on big earnings beat, as drugstore chain cuts costs
In this article, Walgreens reported fiscal first-quarter earnings and revenue that exceeded expectations by shutting stores and reducing costs to…
Vaccine stocks fall as Senate panel advances RFK Jr.’s HHS secretary nomination
Shares of vaccine companies experienced a decline on Tuesday following a Senate panel’s decision to move forward with Robert F.…
Senate panel advances RFK Jr.’s nomination to be health secretary
Robert F. Kennedy Jr. achieved a significant milestone on Tuesday as a Senate panel voted to move forward his nomination…
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
In this article, Eli Lilly will invest $4.5 billion to establish the Lilly Medicine Foundry, a center focused on enhancing…
Biogen tops estimates, raises profit guidance as Alzheimer’s drug Leqembi gains traction
In this article, Biogen reported third-quarter revenue and adjusted earnings that exceeded expectations while also raising its full-year profit guidance.…